Industry News
Update: Big Pharma mega-merger dramarama
Merck and Schering-Plough; Pfizer and Wyeth; Roche and Genentech [ + ]
Applications closing for ISF Congress
Those hoping to participate in the World Congress on Oils and Fats & 28th ISF Congress, held 27–30 September in Sydney, must get their applications in soon with the call for papers closing on 29 March.
[ + ]Arana completes Phase II
Antibody company Arana completes Phase II trial of anti-TNF drug for psoriasis [ + ]
$10m researchers in business scheme announced
A $10 million program to help Australian inventions get to market was launched by the Minister for Innovation, Industry, Science and Research, Kim Carr, at the Universities Australia conference in Canberra, recently.
[ + ]Ring around a rosella
The crimson rosella is not the only colour in town – P. elegans also comes in orange and yellow shades. [ + ]
Drag lizards, queens of the desert
She-male lizards deceive competitors by sight but not smell [ + ]
Implicit licence from Lilly
Brisbane biopharma Implicit buys antibody program from Eli Lilly [ + ]
PiggyBacking stem cells to pluripotency
Researchers induce pluripotent stem cells without viral vectors [ + ]
Website updated
The Pacific Laboratory Products website has been refreshed, with a different colour to represent each customer market.
[ + ]Cephalon offers $318 million for Arana
US company Cephalon named as the bidder for Arana [ + ]
Time to get out now: PwC
Biotech: shut up shop now if writing’s on the wall [ + ]
Yeast model for Parkinson’s
Complex links between alpha-syn, PARK9 and manganese shown in yeast model [ + ]
Takeover bid for Arana
Cash-rich Arana Therapeutics in discussion about takeover [ + ]
Extra heart recruits for Mesoblast
Good preliminary data allows further patient recruitment for heart stem cells [ + ]
Favourable West Nile vaccine results
Encouraging Phase I trial results for West Nile virus vaccine released [ + ]
